Skip to main content

MoneyWorks4Me

Nutraplus India informs about quarterly statement on investor complaints

12 Apr 2016 Evaluate

Nutraplus India has informed about Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended March 31, 2016, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1870.05
Dr. Reddys Labs. 1387.00
Cipla 1383.00
Lupin 1953.90
Zydus Lifesciences 1202.70
View more..